Literature DB >> 1905011

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

R Scharfmann1, J H Axelrod, I M Verma.   

Abstract

Toward the goal of gene therapy, we have been attempting to establish model somatic cell systems with the potential of sustained expression of the foreign gene. We report here that long-term expression of foreign genes in mouse embryo fibroblast implants can be achieved if a housekeeping gene promoter is used to drive transcription. Specifically, we have shown that in implants containing a beta-galactosidase gene linked to either an immediate early promoter of cytomegalovirus or a dihydrofolate reductase (DHFR) gene promoter, only the DHFR promoter allows long-term expression. We propose that choice of the promoter manifests significant influence on the long-term expression of genes introduced in fibroblast implants by retroviral vectors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905011      PMCID: PMC51718          DOI: 10.1073/pnas.88.11.4626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Gene therapy.

Authors:  I M Verma
Journal:  Sci Am       Date:  1990-11       Impact factor: 2.142

2.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.

Authors:  J A Nelson; C Reynolds-Kohler; B A Smith
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

3.  Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.

Authors:  J Price; D Turner; C Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.

Authors:  T D Palmer; A R Thompson; A D Miller
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

5.  Factors affecting long-term stability of Moloney murine leukemia virus-based vectors.

Authors:  L Xu; J K Yee; J A Wolff; T Friedmann
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

6.  Retrovirus-mediated transduction of adult hepatocytes.

Authors:  J M Wilson; D M Jefferson; J R Chowdhury; P M Novikoff; D E Johnston; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

7.  Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells.

Authors:  E A Dzierzak; T Papayannopoulou; R C Mulligan
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

8.  The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids.

Authors:  B Coulomb; L Dubertret; E Bell; R Touraine
Journal:  J Invest Dermatol       Date:  1984-04       Impact factor: 8.551

9.  Analysis of the mouse dhfr promoter region: existence of a divergently transcribed gene.

Authors:  G F Crouse; E J Leys; R N McEwan; E G Frayne; R E Kellems
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

10.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  54 in total

Review 1.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.

Authors:  Teiko Sumiyoshi; Nathalia G Holt; Roger P Hollis; Shundi Ge; Paula M Cannon; Gay M Crooks; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

Review 3.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

4.  Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity.

Authors:  S H Chia; D A Geller; M R Kibbe; S C Watkins; J J Fung; T E Starzl; N Murase
Journal:  Transplantation       Date:  1998-12-15       Impact factor: 4.939

5.  Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.

Authors:  M A Kay; P Baley; S Rothenberg; F Leland; L Fleming; K P Ponder; T Liu; M Finegold; G Darlington; W Pokorny
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.

Authors:  C Laker; J Meyer; A Schopen; J Friel; C Heberlein; W Ostertag; C Stocking
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.

Authors:  Susana Ortiz-Urda; Qun Lin; Cheryl L Green; Douglas R Keene; M Peter Marinkovich; Paul A Khavari
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.

Authors:  S D Rettinger; S C Kennedy; X Wu; R L Saylors; D G Hafenrichter; M W Flye; K P Ponder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Authors:  F Shaheen; L Duan; M Zhu; O Bagasra; R J Pomerantz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.